Quick Update for Bright Green (BGXX) Investors

By Susan Ramirez • Wednesday, May 03 10:39 • Permanent Link

Small-cap health care company Bright Green has moved -3.5% this morning, reaching $1.33 per share. In contrast, the average analyst target price for the stock is $None.

Bright Green Corporation focuses on the propagation, cultivation, and manufacturing of cannabis products. The company is based in the United States.

Make Sure to Consider the Following Before Buying Bright Green:

Bright Green has moved -94.5% over the last year.
Over the last 3 years, earnings per share (EPS) have been growing at a compounded average rate of -100.0%.
Its Price to Book (P/B) ratio is 19.9

Bright Green Has Irregular and Negative Cash Flows

Date Reported	Cash Flow from Operations ($ k)	Capital expenditures ($ k)	FreeCashFlow ($ k)	YoY Growth (%)
2022-12-31	-2,266	-11,680	-13,946	-611.77
2021-12-31	-1,657	-303	-1,959	-281.68
2020-12-31	-513	nan	-513	n/a

None

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.